Fig. 1From: Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancerA Progression Free Survival after the Initiation of Third-line Treatment. B Overall Survival from the Diagnosis. C Overall Survival from the Initiation of Third-line TreatmentBack to article page